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ABSTRACT
Diarrhea is the second leading cause of deaths in children under five - after pneumonia- with 1.5 million deaths per year.
Several studies and meta-analysis, show that low osmolarity oral rehydration salts and zinc, significantly reduce morbidity
and mortality in children with diarrhea. Since 2004, the World Health Organization (WHO) and the United Nations Children’s
Fund (UNICEF) recommended their routine use in children with diarrhea alongside existing preventive measures. Since then,
these recommendations are still not yet put into practice in many countries. This article highlights current available evidence
of the efficacy of low osmolarity oral rehydration salts and zinc  in the management of diarrhea in children. It is hoped this will
raise awareness in policy makers and health personnel to adopt these recommendations so that morbidity and mortality from
diarrhea in children could be curbed.
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PRISE EN CHARGE ACTUELLE DE LA DIARRHEE CHEZ L’ENFANT: De la
théorie et la recherche à la pratique et au pragmatisme.
RESUME
La diarrhée est la deuxième cause de décès chez les enfants de moins de 5 ans  - après la pneumonie- avec 1,5 million de décès
par an. Plusieurs études et meta-analyses ont démontre l’efficacité des sels de réhydratation orale et du zinc dans la réduction
de la morbidité et la mortalité  des enfants avec la diarrhée.  Depuis 2004, l’Organisation Mondial de la Santé (OMS) et le Fonds
des Nations Unies pour l’Enfance (UNICEF) ont recommandé leur utilisation dans la prise en charge de la diarrhée chez
l’enfant en plus des mesures préventives existantes. Depuis lors, ces recommandations ne sont toujours pas mises en œuvre
dans plusieurs pays. Cet article fait la mise au point  des recherches récentes  sur l’efficacité des sels de réhydration orale et
le zinc dans la prise en charge de la diarrhée chez l’enfant. Le but est de sensibiliser les décideurs et le personnel de santé à
adopter ces recommandations afin de réduire la morbidité et  la mortalité chez des enfants avec la diarrhée.
MOTS CLES: Sels de réhydration orale a faible osmolarité – Zinc – diarrhée – Enfants.
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1- INTRODUCTION
According to the World  Health Organization(WHO), an estimated 2.5 billion cases ofdiarrhea occur among children under 5 years
of age each year, and estimates suggest that the overall
incidence has become stable over the past two
decades. More than half of the cases occur in Africa
and South-East Asia, where bouts of diarrhea are likely
to result in death or other severe outcomes. The inci-
dence varies with the season and the child’s age: inci-
dence varies in the first two years and declines
thereafter [1].
Diarrhea is the second leading cause of death among
children under five. Nearly one in five child deaths
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Mortality from diarrhea has declined over the past two
decades from an estimated 5 million deaths among
children under 5 to 1.5 million deaths in 2004, which
parallels downward trends in overall under-five mortality
during this period. Despite these declines, diarrhea
remains the second most common cause of death among
children under 5 globally, following closely behind
pneumonia, the leading killer of young children, and
before malaria [1-2].
Why should diarrhea, an easily preventable and treatable
disease still be causing an estimated 2.5 billion under
five deaths every year? Reducing these deaths depends
not only on preventive measures and the rotavirus
vaccine, but largely on delivering life saving treatment of
low osmolarity oral rehydration salts (ORS) and zinc
tablets to all children with diarrhea. Today, only 39% of
children with diarrhea in developing countries receive
the recommended treatment, and limited trend data
suggest that there has been little progress since 2000
[1].
In this paper we highlight the potential benefits from
current available evidence, of low osmolarity ORS and
zinc in the treatment of diarrhea in children, to incite
health professionals to adopt and implement WHO
recommendations which have proven their worth.
II- FROM RESEARCH TO ADVOCACY
Diarrhea with severe zinc deficiency had been observed
in children in developing countries. Studies linking
diarrheal diseases with zinc deficiency were first
described in reports of low plasma zinc levels in children
with diarrhea [3].
Researchers at the John Hopkin’s School of Public
Health conducted pooled analyses including all available
published and unpublished randomized controlled trials
of the effects of supplementary oral zinc in children aged
less than 5 years with acute or persistent diarrhea, and
found that zinc supplements significantly reduced the
duration of acute and persistent diarrhea in children [4].
Meta-analysis of randomized, controlled studies that had
assessed the therapeutic benefit of zinc supplement in
conjunction with ORS in children under 5 was done.
Acute diarrhea was defined as 3 or 4 loose stools or
more per day and persistent diarrhea as that which has
lasted for 14 days or more. The results showed that
zinc supplementation gave a 15% reduction in the
duration of acute diarrhea and a 24% reduction in those
with persistent diarrhea [4-5].
In the early 1980s, the introduction of ORS led to
significant and continuing decrease in the rate of diarrhea
mortality. Until recently, ORS, increased fluids, and
continuing feeding have been the only recommended
treatments for episodes of non complicated diarrhea.
Although ORS had proven efficacy, researchers
continued to work on developing a new formula that
would allow for more hydration while decreasing the
amount of stool output. As a result, an ORS formula
with lower glucose and sodium (lower osmolarity ORS)
was developed, and has proven to be more effective by
decreasing the need for intravenous therapy, decreasing
stool output and decreasing the rate of vomiting [6-9].
In 2004, WHO and UNICEF issued a joint declaration
on new recommendations for the treatment of diarrhea
as follows [10]:
1. To mothers and other care givers
- Give low osmolarity ORS and home-based fluids to
prevent dehydration.
- Continue feeding (or increase breastfeeding during,
and increase all feeding after the period of diarrhea).
- Recognize signs of dehydration and take the child to a
health provider for ORS or intravenous electrolyte
solution as indicated as well as familiarizing with other
symptoms refining medical treatment (bloody
diarrhea).
- Provide children with 20 mg per day of zinc
supplementation for 10–14 days (10 mg per day for
infants under six months old).
2. To health-care workers
- Counsel mothers to begin administering suitable
available home fluids immediately upon onset of
diarrhoea in a child.
- Treat dehydration with ORS solution (or with an
intravenous electrolyte solution in cases of severe
dehydration).
- Emphasize continued feeding or increased breast-
feeding during, and increased feeding after the
diarrhoeal episode.
- Use antibiotics only when appropriate, i.e. in the
presence of bloody diarrhoea or shigellosis, and abstain
from administering anti-diarrhoeal drugs.
- Provide children with 20 mg per day of zinc
supplementation for 10–14 days (10 mg per day for
infants under six months old).
- Advise mothers of the need to increase fluids and
continue feeding during future episodes.
   Health-care workers treating children for diarrhoea
are encouraged to provide caretakers with two 1-
litre packets of the new ORS, for home-use until the
diarrhoea stops. Caretakers should also be provided
with enough zinc supplements to continue home
treatment for 10–14 days.
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III.2. Zinc
Zinc is the most ubiquitous of all trace elements involved
in human metabolism and facilitates in catalytic, structural
and cellular regulatory functions, of several enzymes.
In its structural role, it facilitates folding of proteins into
three-dimensional configurations stimulating growth in-
utero, childhood and adolescence. Zinc also plays a
major role in the perpetuation of genetic material,
including Deoxyribonucleic acid (DNA), translation of
Ribonucleic acid (RNA) and ultimately cellular division
and a critical role of zinc in the normal functioning of the
gastrointestinal and immune system [18] .
The most common causes of zinc deficiency include:
Inadequate intake of zinc in the daily diet, increase in
the losses of zinc from the body, such as when copper
exposure is high, and when body requirement for zinc
increases for one reason or another (such as when
lactating or pregnant). These conditions tend to occur
more in the elderly, in mothers, and in young children.
Gastrointestinal malabsorption and losses can also lead
to zinc deficiency symptoms [19].
Zinc occurs naturally in many foods in varying amounts.
Good sources of zinc include shellfish (especially
oysters), fish, red meat, poultry, beans, peas, whole
grains, nuts, seeds, eggs and dairy products. Some foods
are also fortified with zinc, such as breakfast cereals. It
is not just the amount of zinc in particular foods that is
important to consider, but also the bioavailability of this
important mineral. That is, the extent to which zinc is
absorbed by the body. For example, although zinc is
present in large amounts in legumes and grains, these
foods also contain phytates (phytates are a stored form
of phosphorous) which bind to zinc and hinder its
absorption in the intestines. Zinc is absorbed more easily
from animal sources. Preparing foods in certain ways
may help to increase the bioavailability of zinc. For
example, soaking grains and beans before cooking, and
the leavening process used to make breads helps to
break down phytates [20].
IV. CURRENT AVAILABLE EVIDENCE OF EFFICACY
OF LOW OSMOLARITY ORS AND ZINC IN DIARRHEA
TREATMENT.
Several meta-analyses of randomized clinical trials have
been done ever since low osmolarity ORS and zinc were
found to be beneficial in the treatment of diarrhea. In
this review, only a summary of the most recent will be
cited.
IV. 1. Low osmolarity ORS and diarrhea
HAHN  et al, in 2009 [21], following a Cochrane meta-
analysis of 8 randomized trials reduced osmolarity ORS
was associated with fewer unscheduled intravenous ûuid
infusions compared with  the WHO standard ORS.
In a multicenter randomized double blind trial in 125
children of 1- 17 years with diarrhea, the recovery of
systemic symptoms, dehydration signs and diarrhea
occurred in 96%, 97% and 78% of patients in the low
osmolarity group [22].  In a joint UNICEF/WHO
statement in 2001, following a meta-analysis of 19 trials
comparing reduced with standard ORS in children with
acute non- cholera diarrhea, it was noted that reduced
osmolarity ORS reduced by 35% the need for IV fluids,
reduced stool output and by 20% in pooled analysis,
significant reduction (30%) in the incidence of vomiting
in children, and a non statistically significant incidence
of hyponatremia in those who received reduced
osmolarity ORS [9].
The same findings were noted by the Choice Study
Group in 2001 [23] following a multicenter double blind,
randomized controlled clinical trial conducted in 675
children of 1 to 24 months with acute diarrhea in 5
developing countries (Bangladesh, Brazil, India, Peru
and Vietnam).
However there have been some reserves with the use
of low osmolarity salts in cholera. In the jointly organized
UNICEF/WHO meeting of experts in India in 2001, it
was recognized and unanimously agreed that low
osmolarity ORS were affective in the treatment of
cholera in children and adults, and that treatment is
associated with and increased risk of transient
hyponatremia [9].
In 2004, in a Cochrane review by MURPHY et al,
randomized controlled trials comparing reduced
osmolarity ORS with standard ORS for treating adults
and children with acute diarrhea due to cholera indicated
that, reduced osmolarity ORS is associated with
biochemical hyponatremia when compared with standard
ORS, although there are similar benefits in terms of other
outcomes. Although this risk does not appear to be
accompanied by serious consequences, the total patient
experience in existing trials is small. Under wider practice
conditions, especially where patient monitoring is
difficult, caution is warranted [24].
The same concerns have been raised by NALIN et al,
in an extensive review comparing the two formulations
[25].
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- Cholera:  Zinc supplementation significantly reduces
the duration of diarrhea and stool output in children with
cholera. Children with cholera should be supplemented
with zinc to reduce its duration and severity [33].
- Shigellosis: zinc supplementation significantly shortens
the duration of acute shigellosis, promotes better weight
gain during recovery and reduces diarrheal morbidity
during the subsequent 6 months [34-35]. Intestinal
permeability improves significantly with resolution of
small mucosal damage [36].
IV-3.Cost effectiveness of zinc supplementation
and oral rehydration salts
The availability of zinc supplements, along with oral
rehydration therapy (ORT)  with appropriate education
programs  was associated with significant higher use of
ORT and lower use of antibiotics which can have an
impact on the emergence of resistant strains of germs
[27,37]. In 2004, ROBBERSTAD et al, also
demonstrated cost-effectiveness of zinc as adjunct
therapy to standard treatment of acute childhood
diarrhea including dysentery in Tanzania [34]. The direct
effect of the reduction in duration and severity of diarrhea
is the decreased need for expensive and prolonged
hospitalizations.
IV-4. Zinc and preventive effects
Supplementation of zinc for 10-14 days has a beneficial
effect in the 2-3 months following treatment with a 34%
reduction in the prevalence of diarrhea [6, 11, 18, 38,
39, 40].   Preventive effects have also been demonstrated
in acute lower respiratory infections with a reduction to
as much as 45% (95% CI: 10%, 67%) in zinc
supplemented children [39, 41]. Beneficial preventive
effects have also been noted with malaria, with zinc
supplemented children having 32% fewer clinical visits
for malaria than non supplemented children [38]. In zinc
supplementation areas children had a 51% lower risk
of non-injury deaths compared to those in areas where
zinc was not available[18,38].
IV-5. Safety and dosages
Supplementation of zinc in the treatment of diarrhea is
safe, effective and inexpensive [6, 42]. The only known
adverse effect is vomiting, and this can be attributed to
a metallic taste in the supplement [6, 30]; and a slight
drop in plasma copper concentrations [42]. The dosage
is 10mg once per day in children less than 6 months,
and 20mg once per day in children above 6 months.
The tablets could be dissolved in breast milk, ORS, or
clean water.
IV-6. Zinc and malnutrition
The usefulness and benefits of zinc in malnutrition is
controversial. In a randomized double-blind To evaluate
the potential benefit of dietary supplementation of a rice-
lentil (khitchri) and yogurt diet with 3 mg/kg/day of
elemental zinc in 87 hospitalized malnourished children
6 to 36 months, The overall weight gain, stool volume,
stool frequency, as well as the time taken for diarrheal
recovery or steady weight gain, were comparable for
both supplemented children and controls. Although there
was satisfactory recovery in malnourished children with
persistent diarrhea receiving the khitchri-yogurt diet,
there was no evidence of improved weight gain or
acceleration of recovery from diarrhea with zinc
supplementation. In contrast, the reduction in plasma
copper levels in zinc-supplemented malnourished
children suggests that caution should be exercised in
supplementing severely malnourished children with zinc
alone [43].
In a randomized, double-blind trial to measure the effects
of zinc supplementation on catch-up growth in severe
protein-energy malnutrition, in 141 children aged
between 6 months and 3 years in a nutritional
rehabilitation unit in Dhaka, Bangladesh, and randomly
assigned to receive elemental zinc by mouth, 1.5 mg/kg
for 15 days, 6.0 mg/kg for 15 days, or 6.0 mg/kg for
30 days, and thereafter were followed-up for a total of
90 days.  It was noted that higher zinc doses were not
associated with significant change in any anthropometric
measurement, but mortality was significantly greater in
children who received high-dose zinc. Possible
explanations to this was that high dose-zinc may have a
direct detrimental effect on the immune system during
sepsis; high-dose zinc supplementation could aggravate
deficiencies of other minerals by decreasing their
intestinal absorption, and also that zinc inhibits copper
absorption  aggravating copper deficiency which can
coexist with severe protein-energy malnutrition. Copper
deficiency is also associated with an impaired immune
response, specifically, a reduction in the antibody
response to T cell–dependent antigens and a decrease
in the microbiocidal activity of phagocytes [5, 44].
IV-7. Mode of action of zinc in diarrhea
Despite the several clinical observations of the efûcacy
of Zn in the treatment of acute diarrhea, the
mechanism(s) by which Zn acts as an antidiarrheal agent
are understood poorly. All of these successful clinical
studies concluded that the possible mechanism for the
beneûcial effect of Zn treatment on the duration of
diarrhea included the following:
Chiabi A.  et al.
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1.  improved absorption of water and electrolytes by
the intestine (by a yet undefined or poorly defined
mechanism),
2.    faster regeneration of gut epithelium,
3.   increased levels of enterocyte brush border enzymes,
4.   an enhanced immune response leading to increased
clearance of the pathogen(s) Responsible for
diarrhea from the intestine [3,45].
However, the physiologic effect of zinc on intestinal ion
transport has not yet been established thoroughly. Neither
are there reports of whether zinc induces cation
absorption and/or inhibits anion secretion, which are all
properties of most anti-diarrheal drugs. Furthermore, it
has not yet been well established whether Zn deûciency
potentiates secretory diarrhea [3]. There is experimental
evidence in rats that zinc inhibits cAMP-stimulated Cl
secretion by selectively inhibiting a cAMP-activated
basolateral K channel. These observations suggest that
Zn may be effective in other cAMP-mediated secretory
diarrheal disorders and that other K-channel blockers
may have the potential for development as anti-diarrheal
agents [3, 46].
V- CONCLUSION
Reduced osmolarity ORS and zinc supplementation
have proven to be the cornerstone of management of
diarrhea in children. As recommended by UNICEF/
WHO and key expert partners, a comprehensive strategy
encompassing interventions as breastfeeding and
hygiene, reduced ORS, zinc supplementation and
rotavirus vaccines can be a highly effective way to reduce
childhood diarrheal diseases in developing countries.
Sensitizing and educating policy makers, health workers,
and parents on the use of zinc and reduced osmolarity
ORS can achieve a remarkable and sustainable impact
on childhood mortality 
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